In patients with melanoma, serial vaccination with CpG oligonucleotides combined with melanoma antigen A protein along with incomplete Freund’s adjuvant led to the induction of tumor antigen specific CD8+ T cell responses [56]. Here, CD8A is linked to melanoma.